Stryker has faced complaints about multiple hip replacement devices, including Rejuvenate and Accolade. Concerns about Accolade have arisen more recently but like Rejuvenate, they include complaints of premature hip failure and severe pain. Patients who experience premature hip failure must often undergo revision surgery to replace their hip implant. In the case of Stryker Accolade, patients complain of catastrophic dislocation of the implant.
In 2014, Stryker reached a settlement worth approximately $1 billion concerning its Rejuvenate Modular Hip and ABG II Modular hip stems. Those lawsuits also alleged patients were at risk of premature failure. Further, because the hip implants were metal-on-metal, patients were at a risk of metallosis caused by metallic debris coming loose from the implant.
READ MORE STRYKER ACCOLADE LEGAL NEWS
With the extension to the settlement, patients who have had both the initial and revision surgeries by December 19, 2016, are eligible to take part in the settlement fund. Patients who already took part in the 2014 settlement or who otherwise resolved their Stryker claims are not eligible to take part in the extended settlement. Those who were eligible for the 2014 settlement but did not enroll in it are again eligible to do so, but they must enroll by January 9, 2017.
Settlement values start at around $300,000 but individuals who suffered complications that required additional medical treatment could be eligible for a higher amount.